Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3076296 | Neurología | 2010 | 6 Pages |
Abstract
The main determinant of ABT outcome is early recanalization but the most effective therapeutic option remains to be clarified. The BASICS prospective registry showed no superiority of intra-arterial over intravenous thrombolysis. Therefore, in the absence of contraindications, intravenous thrombolysis should be started as soon as possible and can be used as the main therapy when interventional procedures are not available. However, recent case series have reported high rates of functional independence (50%) after staged escalation therapy (ultra-early intravenous thrombolysis followed by on-demand endovascular mechanical thrombectomy). These results represent a hope for patients and neurologists and reinforce the need for innovation and research in this field.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
J.F. Arenillas Lara,